CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.

 

Begin main content

Reports

We found 7216 result(s)

Optimal Strategies for the Diagnosis of Acute Pulmonary Embolism

Last Updated: March 1, 2018
Result type: Reports
Product Line: Optimal Use
Research Type: Other Diagnostics

Pulmonary embolism (PE) is a blockage of one of the arteries in the lung, frequently caused by a blood clot that has travelled to the lung from another part of the body. If left untreated, it can be fatal in up to 30% of patients. Computed tomography (CT) is the most commonly used imaging modality to diagnose PE. CT is associated with radiati...

  • Project Number: OP0528-000

Public Health 2017

Event Date: June 6, 2017 - June 8, 2017
Result type: Events

CADTH is proud to be a “Friends of Public Health” sponsor of Public Health 2017, the annual conference of the Canadian Public Health Association (CPHA). Public Health 2017 is a national forum for public health professionals, researchers, policy-makers, academics, students and trainees to strengthen efforts to improve health and well-being,...

Apomorphine (Movapo)

Last Updated: April 18, 2018
Result type: Reports
Product Line: Reimbursement Review
Generic Name: apomorphine hydrochloride
Indications: Parkinson's disease

  • Brand Name: Movapo
  • Manufacturer: Paladin Labs Inc.
  • Project Number: SR0527-000
  • Project Status: Complete
  • Submission Type: Initial